ABOM® HEET active anti-fog tactical eyewear receives APEL® nod
By Akshay Kedari  Date: 2019-10-15

ABOM® HEET active anti-fog tactical eyewear receives APEL® nod

Ski goggles are a must for skiers as they protect eyes from snow, wind, and harmful UV rays, while improving vision to see obstacles more clearly. In a bid to enhance the quality and efficiency of ski googles, companies are now introducing new technologies and innovations in their products.

Abom, Inc., made a similar development recently when it announced that its ABOM HEET® tactical eyewear goggle, that incorporates an active anti-fog eyewear goggle system, was approved by the Authorized Protective Eyewear List (APEL).

Recently, the company concluded the U.S. ARMY – PM SPE (Product Manager Soldier Protective Equipment) audit along with a complete compliance check for APEL qualification. Apparently, ABOM®HEET Goggle platform fulfilled each and every qualification criterion listed by MIL-PRF-32432A and Military Combat Eye Protection Program (MCEP).

Reports cite that the google met the military’s ANSI Z87.1-2015 & Z87.1+ High Mass and High-Velocity Impact Standards as well as the MIL-PRF-32432A Ballistic Standard, making it the only active anti-fog goggle to fulfill ANSI ratings.

Speaking on the development, Jack Cornelius, President, Abom, said that the company has always made it its priority to fulfill all the highest possible standards of performance and quality. He claims that expanding the manufacturing of major tactical goods such as the HEET in America will help the company to further develop its commodities.

Sources suggest that the approval from APEL would help Abom increase its American manufacturing capabilities and expand R&D efforts and sales growth into latest technologies like the Augmented Reality HUD integration and Laser Rejection Lenses.

Incidentally, Abom also recently launched its new P3 AR Goggle design, which includes an array of integrated image sensors and superior embedded electronics applications and VX Inc. CNED AR display technology to meet the requirements of AR used in Industrial, Military and Safety market applications.

According to Kyle Cherry, CEO, VX Inc., ABOM’s P3 AR goggle solution efficiently combines its patented power thin-film ultra-low technology, eliminating the possibility of fog to stick on the inner surface of the googles.

Source credit: https://www.businesswire.com/news/home/20191013005014/en/ABOM%C2%AE-HEET-Receives-APEL%C2%AE-Approval

About Author

Akshay Kedari    

Akshay Kedari

A qualified computer engineering graduate, Akshay Kedari takes pride in having his way with words. Following his passion for content creation, he writes insightful pieces on aeresearch.net and a few other portals. Also endorsed with a short-term experience in web deve...

Read More

More News By Akshay Kedari

Fibonacci Brands acquires Darwin from Harvest Health & Recreation
Fibonacci Brands acquires Darwin from Harvest Health & Recreation
By Akshay Kedari

Fibonacci Brands has recently announced the acquisition of Darwin from Harvest Health & Recreation (HARV.CN) as its foundation brand. Fibonacci is a leading player in the international cannabis industry. According to James George, founder of Fib...

GVN adds EVIT Center and Chumakov as its new Centers of Excellence
GVN adds EVIT Center and Chumakov as its new Centers of Excellence
By Akshay Kedari

The Global Virus Network (GVN), an international coalition of medical virologists, has recently announced the addition of Australian and Russian researchers. GVN is adding the Center for EVIT (Emerging Viruses, Inflammation & Therapeutics) of th...

Wind Point Partners takes over RTIC to expand business portfolio
Wind Point Partners takes over RTIC to expand business portfolio
By Akshay Kedari

American private equity firm, Wind Point Partners has recently signed an acquisition deal with the one of the biggest direct-to-consumer (D2C) eCommerce providers of drinkware, RTIC. Reportedly, RTIC is Wind Point’s third acquisition of a famil...

Novartis reveals positive data from Phase III ORION trials of inclisiran
Novartis reveals positive data from Phase III ORION trials of inclisiran
By Akshay Kedari

Swiss multinational pharmaceutical firm, Novartis has recently announced results from its Phase III ORION-10 and -11 studies that focus on assessing the individual responses of patients on lowering low-density lipoprotein cholesterol (LDL-C) with inc...

Medtronic to acquire Companion Medical to expand diabetes business
Medtronic to acquire Companion Medical to expand diabetes business
By Akshay Kedari

Medtronic plc, the global leader in medical technologies, has reportedly announced that it is planning to acquire insulin pen manufacturer Companion Medical. The acquisition gives Medtronic access to Companion Medical’s ‘InPen’, wh...